Radiotherapy and Breast Reconstruction: What Is the Ideal Timing? A Narrative Review

Author:

Tolia Maria1,Letsiou Evanthia2,Tsakatikas Sergios3,Vakis George4,Tsapakidis Konstantinos5,Charalampakis Nikolaos3,Diamantis Alexandros6,Poultsidi Antigoni6,Michelakis Dimosthenis7,de Bree Eelco7,Mauri Davide89,Tsoukalas Nikolaos10,Antoniades Chrysostomos1

Affiliation:

1. Department of Radiotherapy, School of Medicine, University of Crete, 711 10, Heraklion, Greece

2. Medical School, University of Thessaly, 415 00 Larissa, Greece

3. Department of Medical Oncology, Metaxa Cancer Hospital, 185 37 Athens, Greece

4. Plastic Surgery Clinic, Evangelismos General Hospital, Ipsilantou 45-47, 106 76, Athens, Greece

5. Department of Oncology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Biopolis, 41500, Larisa, Greece

6. Department of Surgery, Medical School, University of Thessaly, 415 00 Larissa, Greece

7. Department of Surgical Oncology, Medical School of Crete University Hospital, 711 10 Heraklion, Greece

8. Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece

9. Department of Medical, Oncology, Greece Society for Study of Clonal Heterogeneity of Neoplasia (EMEKEN), University Hospital of Ioannina, Ioannina, Greece

10. Department of Oncology, 401 General Military Hospital of Athens, 115 25, Athens, Greece

Abstract

Introduction:Women undergoing mastectomy choose to pursue breast reconstruction (BR) in order to reduce their body image distress.Adjuvant chest wall irradiation is associated with a negative cosmetic outcome. The aim of our review was to identify the optimal timing of BR relating to radiotherapy delivery.Materials and Methods:Using Cochrane Library, Embase, PubMed, Springer, Wanfang and CNKI, we performed a non-systematic review of articles published up to August 2021.Result:There is no hard evidence in favor of immediate, delayed or 2-stage BR when post-mastec-tomy radiation is indicated. Immediate and 2-stage BR seem to be valid alternatives to delayed BR.Conclusion:Further research is essential in order to assess clinician and patient reported aesthetic outcomes and determine the optimal timing of BR in view of post-mastectomy radiotherapy, in breast cancer survivors.

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3